glp-1 menopause Microdosing During Menopause: Is it Right for You? Menopause Hormone Therapy May Boost
Description
[DOI] [PubMed] [Google Scholar] 23.Mechanisms of action and therapeutic application of glucagon-like-1

RNA-sequencing data were analysed using right-tailed Fishers exact test within the Ingenuity Pathway Analysis database

While many people lose weight when taking these drugs, a large number regain it after stopping

GLP-1 receptor is expressed in human stomach mucosa: analysis of its cellular association and distribution within gastric glands

On the flip side, the normalization of using medication for weight management could reduce stigma around obesity as a solely lifestyle issue, reinforcing that biological factors are at play and medical help is legitimate
